buserelin has been researched along with norethindrone acetate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuhl, H; Pietzsch, V | 1 |
| Hoffmann, G; Pollow, K; Schommer, M; von der Ohe, M | 1 |
| Hardt, W; Nevinny-Stickel, J; Schmidt-Gollwitzer, K; Schmidt-Gollwitzer, M | 1 |
| Gold, E; Goulding, A | 1 |
1 trial(s) available for buserelin and norethindrone acetate
| Article | Year |
|---|---|
LHRH agonist and contraception.
Topics: Adolescent; Adult; Buserelin; Clinical Trials as Topic; Contraceptive Agents, Female; Endometrium; Estradiol; Female; Humans; Luteinizing Hormone; Norethindrone; Norethindrone Acetate; Progesterone | 1986 |
3 other study(ies) available for buserelin and norethindrone acetate
| Article | Year |
|---|---|
[Contraception with cyclic administration of buserelin and gestagens: increase in testosterone and free testosterone serum concentration].
Topics: Administration, Intranasal; Adult; Buserelin; Contraceptives, Oral, Combined; Female; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Protein Binding; Testosterone | 1991 |
[Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
Topics: Adult; Buserelin; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Evaluation; Endometrium; Estradiol; Female; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Menstruation; Norethindrone; Norethindrone Acetate; Ovulation; Patient Acceptance of Health Care; Substance Withdrawal Syndrome; Uterine Hemorrhage | 1982 |
Norethindrone acetate only partially protects the skeleton of rats treated with the LHRH agonist buserelin from oestrogen-deficiency osteopaenia.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Buserelin; Calcium; Disease Models, Animal; Estradiol; Estrogens; Female; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Rats | 1993 |